Skip to main content

Table 1 Demographic and clinical characteristics of patients with Gaucher disease type 1 (n = 19)

From: Follow-up of pre-motor symptoms of Parkinson’s disease in adult patients with Gaucher disease type 1 and analysis of their lysosomal enzyme profiles in the CSF

Patient

Gender

Age (years)

Genotype

Treatment duration (years)

Current treatment

Platelets (× 109/L)

Hb (g/dL)

Lyso-Gb1 (nmol/L)

ChT activity (nmol/hr./mL)

Severity scores

SSI

DS3

1

M

26

N370S/G202R

18

ERT

171

14.9

234.1

4951

0

0.66

2

F

27

N370S/L444P

6

ERT

225

12.5

127.0

3095

1

0

3

F

29

N370S / L444P

13

ERT

166

11.5

61.6

425

1

0

4

M

30

N370S/IVS9 + 1G > A

19

ERT

149

15.4

453.0

1988

3

1.25

5

F

31

N370S/RecNciI

22

SRT

146

11.6

371.0

3699

0

2.5

6

F

32

N370S/L461P + IVS10 + 1G > T

28

ERT

162

12.9

NA

7044

3

1.06

7

M

35

N370S/RecNciI

21

ERT

212

16.1

77.0

1243

3

1

8

F

37

N370S/L444P

19

ERT

182

13.3

192.7

2306

0

0

9

F

43

N370S/ RecNciI

7

ERT

221

13.0

589.0

736

2

1

10

M

42

N370S/L444R

11

ERT

142

14.4

112.0

1194

0

0

11

F

44

N370S/L444R

14

ERT

171

15.0

122.0

3022

1

0.66

12

M

46

N370S/L444P

17

ERT

290

13.2

NA

2495

4

4.7

13

M

49

N370S / L444P

10

ERT

199

14.4

15.0

116

5

0.4

14

F

53

E349K/S366N

10

ERT

285

14.7

23.6

643

3

1.8

15

F

55

N370S/RecNciI

20

ERT

405

14.7

113.0

1216

5.66

13

16

M

61

N370S/RecNciI

10

ERT

160

16.1

64.6

1170

3

0

17

F

66

N370S/RecNciI

24

ERT

153

13.8

70.0

581

22

2.4

18

M

68

N370S/N370S

12

ERT

160

14.2

85.8

1529

0

0.5

19

F

71

N370S/L444R

11

ERT

309

13.9

120.6

257

10

4.5

  1. ERT enzyme replacement therapy. SRT substrate reduction therapy. SSI Zimran Severity Score Index (mild = 0–10; moderate = 11–19; severe ≥ 20). DS3 Disease Severity Score (mild =  < 3.00; moderate = 3.00–5.99; marked = 6.00–19). Hb hemoglobin. Plat platelet count. lyso-Gb1 glucosylsphingosine (normal range: < 12 nmol/L) ChT chitotriosidase activity (normal range: < 78.5 nmol/hr./mL). NA not available